Evidence map›Paper›PMID 40469085›Full record

ArticleFrontiers in antibiotics2025

The burden, risk factors, and antimicrobial susceptibility pattern associated with extended-spectrum beta-lactamase-producing

Happyness J Mshana, Dorottya Kovacs, Florida Muro, Ruth Zadoks, Katarina Oravcova, Louise Matthews, Blandina T Mmbaga

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in antibiotics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Trends in Antibiotic Resistance ofPathogens (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Happyness J MshanaDepartment of Research and Clinical Trial, Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
Dorottya KovacsBoyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Florida MuroDepartment of Research and Clinical Trial, Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
Ruth ZadoksBoyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Katarina OravcovaBoyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Louise MatthewsBoyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Blandina T MmbagaDepartment of Research and Clinical Trial, Kilimanjaro Clinical Research Institute, Moshi, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Infections are a major driver of broad-spectrum antibiotic use. This wide use of antibiotics contributes to the emergence of antimicrobial resistance globally that poses a threat to human and animal health. Infections continue to be a major cause of death among pregnant women and neonates. Therefore, this study aimed to assess the burden of extended-spectrum beta-lactamase (ESBL)-producing Methodology: The burden of ESBL-producing Results: A total of 437 neonates were screened for ESBL-producing Conclusion: The study reveals a high burden of ESBL-producing

Indexed as

antimicrobial susceptibilityburdenextended-spectrum beta-lactamase (ESBL)neonatesrisk factor

Identifiers

PMID40469085
PMCPMC12134566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.